Developer docs
API playgroundTry for free, no card

Search company profiles

Invibio

Full company profile

uuid000atkr

Namestring
Invibio
Legal namestring
Invibio Limited
Websiteurl
invibio.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Invibio Limited is a UK-based subsidiary of Victrex plc (LSE: VCT) that supplies implant-grade PEEK polymers and biomaterial solutions to medical device manufacturers worldwide. The company was formed in the 1990s and introduced PEEK-OPTIMA in 1999 as the world's first implantable PEEK polymer; PEEK-OPTIMA has since been used in over 15 million implanted devices with zero material-related recalls. Its portfolio includes PEEK-OPTIMA base grades, PEEK-OPTIMA HA Enhanced (hydroxyapatite-blended for bone ongrowth), PEEK-CLASSIX (non-implantable medical grade), PEEK-OPTIMA AM filament for additive manufacturing (launched March 2023), and VICTREX PC for pharmaceutical contact applications. The business operates a B2B enterprise go-to-market, selling materials under qualification-and-supply agreements to spine, orthopedics, trauma, and broader medical device OEMs, while layering technical, regulatory, and development services on top via the Leeds product development and manufacturing centre (opened 2023) and an Innovation Partnership Program. Customer concentration is distributed across multiple enterprise OEMs (NG Medical, Omnia Medical, Spinal Elements, Maxx Orthopedics, In2Bones, Nvision, Weigao, Beijing Fule, Double Medical), supplemented by surgeon engagement through a Surgeon Education Network. Direct revenue figures are not publicly broken out; pricing is quote-based and undisclosed, and the model combines one-time material sale transactions with embedded technical and regulatory service revenue.

Short descriptiontext

Invibio supplies implant-grade PEEK polymers and biomaterial solutions (notably PEEK-OPTIMA) to medical device manufacturers for use in spine, orthopedic, trauma, and other implantable devices, operating as the medical division of Victrex plc with a B2B enterprise sales model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLancaster, United Kingdom
HQ citystring
Lancaster
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Implantable PEEK polymers, Medical grade biomaterials, Spinal implant materials, Orthopedic polymer solutions, Drug delivery polymers
Industry4 codes
1Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
CodeHLAHAEABPrimaryYes
23D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
3Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryNo
4Medical & Dental Prototyping (Models, Guides, Pre-Op Planning)
CodeIMAAAFAIPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Biomaterials (Implantable PEEK Polymers)
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1PEEK Polymer Materials Sales
TypeOne Time License
Description

Invibio generates revenue through the sale of implant-grade PEEK polymer materials (PEEK-OPTIMA, PEEK-CLASSIX) to medical device manufacturers for use in spinal, orthopedic, trauma, and other medical implants.

invibio.com
2Technical and Regulatory Support Services
TypeProfessional Services
Description

Revenue generated from providing technical expertise, regulatory support, testing, validation, and scale-up services to medical device companies throughout the product development and commercialization process.

invibio.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1PEEK-OPTIMA™
Description

World's first implantable PEEK polymer with over 20 years of proven clinical history and zero material-related recalls.

invibio.com
+1 more record
Core offering1 text field

Invibio manufactures and supplies implant-grade PEEK polymers and biomaterial solutions to medical device companies. Its core product family, PEEK-OPTIMA, includes standard implantable grades, hydroxyapatite-enhanced (HA Enhanced) grades for bone ongrowth, AM filament for 3D printing of patient-specific implants, PEEK-CLASSIX for non-implantable medical device components, and VICTREX PC pharmaceutical-contact grades. The portfolio supports spinal cages, trauma fixation, knee arthroplasty, active implants, and drug delivery applications, paired with regulatory and technical support services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Zero material-related recalls across all applications in 20+ years
+1 more record
Product overview1 text field

Invibio is a leading provider of implant-grade PEEK polymers and biomaterial solutions for medical device manufacturers. The company's core product is PEEK-OPTIMA, the world's first implantable PEEK polymer, offered alongside variants like PEEK-OPTIMA HA Enhanced (hydroxyapatite-enhanced for bone ongrowth) and PEEK-CLASSIX for non-implantable applications. Invibio provides specialized solutions including additive manufacturing filaments (PEEK-OPTIMA AM), composite trauma plates, knee replacement components, and pharmaceutical contact grades (VICTREX PC). The portfolio serves application areas spanning spine & orthopedics (spinal cages, hip & knee, sports medicine), trauma (CMF, foot & ankle, fracture fixation), and medical devices (active implants, drug delivery). The company supports medical device companies from concept to commercialisation through materials, regulatory support, and technical expertise.

Product and service7 records
1PEEK-OPTIMA Polymers
CategoryImplantable PEEK polymer (core material)
Description

Implantable-grade PEEK polymer with over 20 years of clinical history and zero material-related recalls. Used in spinal cages, hip & knee implants, trauma devices, and other implantable medical devices. Designed for medical device manufacturers seeking biocompatible, radiolucent, bone-like modulus materials cleared under FDA 510(k), CE Mark, and MDR pathways.

2PEEK-OPTIMA HA Enhanced
CategoryImplantable PEEK polymer variant
Description

Hydroxyapatite-enhanced PEEK polymer grade that supports bone ongrowth across the entire implant surface, combining the osseo-integrative benefits of titanium with PEEK's radiolucency and bone-like modulus. For medical device manufacturers developing implants requiring enhanced bone bonding.

3PEEK-OPTIMA AM Filament
CategoryAdditive manufacturing material
Description

Implantable PEEK filament specifically designed for 3D printing of medical implants, enabling patient-specific and complex-geometry implantable devices through additive manufacturing. For medical device manufacturers seeking to produce custom or geometrically complex implants.

4PEEK-CLASSIX
CategoryNon-implantable PEEK polymer
Description

PEEK polymer grades for medical device manufacturing applications, providing biocompatible PEEK options for non-implantable medical device components.

5VICTREX PC (Pharmaceutical Contact Grade PEEK)
CategoryPharmaceutical-contact PEEK polymer
Description

PEEK polymer specifically developed for pharmaceutical-contact applications, enabling use in drug delivery devices requiring regulatory compliance for pharmaceutical contact materials.

6Composite Trauma Plates
CategoryComposite biomaterial solution
Description

PEEK-based composite materials developed for trauma repair and reconstruction, enabling lighter, more flexible devices that maintain high strength and imaging compatibility for fracture fixation applications. For medical device manufacturers producing trauma, CMF, and extremity reconstruction devices.

7Knee Replacement Solutions
CategoryOrthopedic biomaterial solution
Description

PEEK-OPTIMA polymer femoral components and related materials for total knee arthroplasty, offering an alternative to metal with bone-like modulus and MRI compatibility. For orthopedic device manufacturers developing knee replacement systems.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

New collaboration announced in 2023 for medical device development partnership.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Cooperation leading to the first POHAE (PEEK-OPTIMA HA Enhanced) cage in China, marking a significant milestone for PEEK-based implants in the Chinese market.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Collaboration for extremity reconstruction devices using PEEK biomaterials.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

FDA clearance obtained for osteotomy wedge system using Invibio's PEEK materials.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-01-01
Description

Partnership to drive implantable devices using PEEK-OPTIMA into the China market, leveraging Double Medical's local distribution capabilities.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

Partnership with UK Olympic sprinter James Ellington on new passion project, demonstrating Carbofix's orthopedic devices.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

Collaboration on knee-replacement technology using PEEK-OPTIMA polymers, including joint development and US IDE approval for PEEK-OPTIMA Total Knee Arthroplasty Study in 2024.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

Collaboration with China's Weigao on spinal implant development and market introduction, leveraging local market expertise with Invibio's biomaterial technology.

Strategic tierCoreTypeOthers
Description

Victrex is the parent company of Invibio, providing world-class manufacturing and supply chain capabilities. Invibio leverages Victrex's polymer expertise and global supply chain for consistent material availability and quality assurance.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Syensqo is a specialty materials company producing high-performance polymers including medical-grade PEEK for implantable devices. As a direct competitor in the medical polymer materials space, it shares Invibio's customer base of spine and orthopedic device manufacturers.

TypeDirect peer
Description

Solvay supplies high-performance specialty polymers including medical-grade offerings that compete with Invibio's PEEK portfolio in implantable and medical device markets. As a large diversified chemical manufacturer, it competes on scale, regulatory support, and downstream polymer customization.

TypeEmerging player
Description

EOS supplies industrial 3D printing systems, including polymer printing platforms used for medical implant production. As an AM hardware partner ecosystem for Invibio's PEEK-OPTIMA AM filament, it represents both an enabling technology layer and competitive 3D-printed implant pathway.

TypeDirect peer
Description

Evonik produces VESTAKEEP implantable-grade PEEK polymers, serving medical device manufacturers with biomaterials analogous to Invibio's PEEK-OPTIMA. Both compete directly as implant-grade PEEK suppliers to spine and orthopedic OEMs, with comparable regulatory clearances and device integration targets.

TypeBroad incumbent
Description

Mitsubishi Chemical supplies engineering plastics including high-performance polymers used in medical device applications. While broader in portfolio, its medical polymer offerings overlap with Invibio's PEEK solutions for implantable and surgical device manufacturers.

TypeEmerging player
Description

Carbofix develops carbon fiber-reinforced PEEK composite orthopedic devices and is a partner/customer of Invibio. As a device OEM, it represents the downstream use case of Invibio's polymer materials in trauma and spine applications.

TypeDirect peer
Description

DSM Biomedical supplies biomaterials and medical device materials—including polymers used in implantables—to medical device OEMs, directly competing with Invibio on biomaterial solutions across spine, orthopedics, and cardiovascular device applications.

TypeEmerging player
Description

3D Systems provides healthcare 3D printing solutions including patient-specific implants and surgical planning. Its implant offerings create both a complementary ecosystem for Invibio's PEEK-OPTIMA AM filament and a competing patient-specific implant modality.

TypeEmerging player
Description

Maxx Orthopedics is the development partner with Invibio on the PEEK-OPTIMA Total Knee Arthroplasty program with FDA IDE approval. It represents a key downstream commercialization channel and use-case validator for Invibio's biomaterial innovation in joint reconstruction.

10Victrex plc
TypeBroad incumbent
Description

Invibio's parent company and the original inventor of PEEK polymer with integrated monomer-to-polymer manufacturing. Victrex supplies the same PEEK polymer feedstock that Invibio qualifies for medical use, making it the closest comparator on underlying chemistry and supply chain scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Invibio

Medical Biomaterials (Implantable PEEK Polymers)invibio.com

Invibio supplies implant-grade PEEK polymers and biomaterial solutions (notably PEEK-OPTIMA) to medical device manufacturers for use in spine, orthopedic, trauma, and other implantable devices, operating as the medical division of Victrex plc with a B2B enterprise sales model.

What Invibio does

Invibio Limited is a UK-based subsidiary of Victrex plc (LSE: VCT) that supplies implant-grade PEEK polymers and biomaterial solutions to medical device manufacturers worldwide. The company was formed in the 1990s and introduced PEEK-OPTIMA in 1999 as the world's first implantable PEEK polymer; PEEK-OPTIMA has since been used in over 15 million implanted devices with zero material-related recalls. Its portfolio includes PEEK-OPTIMA base grades, PEEK-OPTIMA HA Enhanced (hydroxyapatite-blended for bone ongrowth), PEEK-CLASSIX (non-implantable medical grade), PEEK-OPTIMA AM filament for additive manufacturing (launched March 2023), and VICTREX PC for pharmaceutical contact applications. The business operates a B2B enterprise go-to-market, selling materials under qualification-and-supply agreements to spine, orthopedics, trauma, and broader medical device OEMs, while layering technical, regulatory, and development services on top via the Leeds product development and manufacturing centre (opened 2023) and an Innovation Partnership Program. Customer concentration is distributed across multiple enterprise OEMs (NG Medical, Omnia Medical, Spinal Elements, Maxx Orthopedics, In2Bones, Nvision, Weigao, Beijing Fule, Double Medical), supplemented by surgeon engagement through a Surgeon Education Network. Direct revenue figures are not publicly broken out; pricing is quote-based and undisclosed, and the model combines one-time material sale transactions with embedded technical and regulatory service revenue.

Invibio firmographics

Firmographics
Name
Invibio
Legal name
Invibio Limited
Website
https://invibio.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
101–250 employees
Short description
Invibio supplies implant-grade PEEK polymers and biomaterial solutions (notably PEEK-OPTIMA) to medical device manufacturers for use in spine, orthopedic, trauma, and other implantable devices, operating as the medical division of Victrex plc with a B2B enterprise sales model.
Ownership category
akta.pro rank

Invibio industry classification

Industry
Product category
Medical Biomaterials (Implantable PEEK Polymers)
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)
akta.pro secondary industries
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), Medical & Dental Prototyping (Models, Guides, Pre-Op Planning) (IMAAAFAI)

Keywords

  • Implantable PEEK polymers
  • Medical grade biomaterials
  • Spinal implant materials
  • Orthopedic polymer solutions
  • Drug delivery polymers

Where Invibio is headquartered

Location

Headquarters

HQ city
Lancaster
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Invibio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales

Revenue model

  1. PEEK Polymer Materials Sales: Invibio generates revenue through the sale of implant-grade PEEK polymer materials (PEEK-OPTIMA, PEEK-CLASSIX) to medical device manufacturers for use in spinal, orthopedic, trauma, and other medical implants.
  2. Technical and Regulatory Support Services: Revenue generated from providing technical expertise, regulatory support, testing, validation, and scale-up services to medical device companies throughout the product development and commercialization process.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Invibio product offering

Product offering

Core offering

Invibio manufactures and supplies implant-grade PEEK polymers and biomaterial solutions to medical device companies. Its core product family, PEEK-OPTIMA, includes standard implantable grades, hydroxyapatite-enhanced (HA Enhanced) grades for bone ongrowth, AM filament for 3D printing of patient-specific implants, PEEK-CLASSIX for non-implantable medical device components, and VICTREX PC pharmaceutical-contact grades. The portfolio supports spinal cages, trauma fixation, knee arthroplasty, active implants, and drug delivery applications, paired with regulatory and technical support services.

Product overview

Invibio is a leading provider of implant-grade PEEK polymers and biomaterial solutions for medical device manufacturers. The company's core product is PEEK-OPTIMA, the world's first implantable PEEK polymer, offered alongside variants like PEEK-OPTIMA HA Enhanced (hydroxyapatite-enhanced for bone ongrowth) and PEEK-CLASSIX for non-implantable applications. Invibio provides specialized solutions including additive manufacturing filaments (PEEK-OPTIMA AM), composite trauma plates, knee replacement components, and pharmaceutical contact grades (VICTREX PC). The portfolio serves application areas spanning spine & orthopedics (spinal cages, hip & knee, sports medicine), trauma (CMF, foot & ankle, fracture fixation), and medical devices (active implants, drug delivery). The company supports medical device companies from concept to commercialisation through materials, regulatory support, and technical expertise.

Differentiator

Problem solved

Functional benefit

Brands

  • PEEK-OPTIMA™: World's first implantable PEEK polymer with over 20 years of proven clinical history and zero material-related recalls.
  • PEEK-OPTIMA AM

Products and services

  • PEEK-OPTIMA Polymers Implantable-grade PEEK polymer with over 20 years of clinical history and zero material-related recalls. Used in spinal cages, hip & knee implants, trauma devices, and other implantable medical devices. Designed for medical device manufacturers seeking biocompatible, radiolucent, bone-like modulus materials cleared under FDA 510(k), CE Mark, and MDR pathways.
  • PEEK-OPTIMA HA Enhanced Hydroxyapatite-enhanced PEEK polymer grade that supports bone ongrowth across the entire implant surface, combining the osseo-integrative benefits of titanium with PEEK's radiolucency and bone-like modulus. For medical device manufacturers developing implants requiring enhanced bone bonding.
  • PEEK-OPTIMA AM Filament Implantable PEEK filament specifically designed for 3D printing of medical implants, enabling patient-specific and complex-geometry implantable devices through additive manufacturing. For medical device manufacturers seeking to produce custom or geometrically complex implants.
  • PEEK-CLASSIX PEEK polymer grades for medical device manufacturing applications, providing biocompatible PEEK options for non-implantable medical device components.
  • VICTREX PC (Pharmaceutical Contact Grade PEEK) PEEK polymer specifically developed for pharmaceutical-contact applications, enabling use in drug delivery devices requiring regulatory compliance for pharmaceutical contact materials.
  • Composite Trauma Plates PEEK-based composite materials developed for trauma repair and reconstruction, enabling lighter, more flexible devices that maintain high strength and imaging compatibility for fracture fixation applications. For medical device manufacturers producing trauma, CMF, and extremity reconstruction devices.
  • Knee Replacement Solutions PEEK-OPTIMA polymer femoral components and related materials for total knee arthroplasty, offering an alternative to metal with bone-like modulus and MRI compatibility. For orthopedic device manufacturers developing knee replacement systems.

Quantifiable outcome

  • Zero material-related recalls across all applications in 20+ years
  • +1 more outcomes

Companies that use Invibio

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Invibio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Invibio partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered minor and core.

  • Paragon MedicalminorStrategic or Co-development Partner · 1 January 2023New collaboration announced in 2023 for medical device development partnership.
  • Beijing FulecoreStrategic or Co-development Partner · 1 January 2022Cooperation leading to the first POHAE (PEEK-OPTIMA HA Enhanced) cage in China, marking a significant milestone for PEEK-based implants in the Chinese market.
  • In2BonesminorStrategic or Co-development Partner · 1 January 2020Collaboration for extremity reconstruction devices using PEEK biomaterials.
  • NvisionminorStrategic or Co-development Partner · 1 January 2020FDA clearance obtained for osteotomy wedge system using Invibio's PEEK materials.
  • Double MedicalcoreChannel Partner/ Reseller/ Distributor · 1 January 2017Partnership to drive implantable devices using PEEK-OPTIMA into the China market, leveraging Double Medical's local distribution capabilities.
  • CarbofixminorStrategic or Co-development Partner · 1 January 2017Partnership with UK Olympic sprinter James Ellington on new passion project, demonstrating Carbofix's orthopedic devices.
  • Maxx OrthopedicscoreStrategic or Co-development Partner · 1 January 2016Collaboration on knee-replacement technology using PEEK-OPTIMA polymers, including joint development and US IDE approval for PEEK-OPTIMA Total Knee Arthroplasty Study in 2024.
  • WeigaocoreStrategic or Co-development Partner · 1 January 2015Collaboration with China's Weigao on spinal implant development and market introduction, leveraging local market expertise with Invibio's biomaterial technology.
  • VictrexcoreOthersVictrex is the parent company of Invibio, providing world-class manufacturing and supply chain capabilities. Invibio leverages Victrex's polymer expertise and global supply chain for consistent material availability and quality assurance.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Invibio competitors and assessment

Company assessment

Direct peers

  • Syensqo (formerly Solvay Specialty): Syensqo is a specialty materials company producing high-performance polymers including medical-grade PEEK for implantable devices. As a direct competitor in the medical polymer materials space, it shares Invibio's customer base of spine and orthopedic device manufacturers.
  • Solvay (medical-grade PEEK/chemicals): Solvay supplies high-performance specialty polymers including medical-grade offerings that compete with Invibio's PEEK portfolio in implantable and medical device markets. As a large diversified chemical manufacturer, it competes on scale, regulatory support, and downstream polymer customization.
  • Evonik Industries (VESTAKEEP): Evonik produces VESTAKEEP implantable-grade PEEK polymers, serving medical device manufacturers with biomaterials analogous to Invibio's PEEK-OPTIMA. Both compete directly as implant-grade PEEK suppliers to spine and orthopedic OEMs, with comparable regulatory clearances and device integration targets.
  • DSM Biomedical (a dsm-firmenich company): DSM Biomedical supplies biomaterials and medical device materials—including polymers used in implantables—to medical device OEMs, directly competing with Invibio on biomaterial solutions across spine, orthopedics, and cardiovascular device applications.

Emerging players

  • EOS GmbH (additive manufacturing for medical): EOS supplies industrial 3D printing systems, including polymer printing platforms used for medical implant production. As an AM hardware partner ecosystem for Invibio's PEEK-OPTIMA AM filament, it represents both an enabling technology layer and competitive 3D-printed implant pathway.
  • Carbofix Orthopedics: Carbofix develops carbon fiber-reinforced PEEK composite orthopedic devices and is a partner/customer of Invibio. As a device OEM, it represents the downstream use case of Invibio's polymer materials in trauma and spine applications.
  • 3D Systems (medical 3D printing): 3D Systems provides healthcare 3D printing solutions including patient-specific implants and surgical planning. Its implant offerings create both a complementary ecosystem for Invibio's PEEK-OPTIMA AM filament and a competing patient-specific implant modality.
  • Maxx Orthopedics: Maxx Orthopedics is the development partner with Invibio on the PEEK-OPTIMA Total Knee Arthroplasty program with FDA IDE approval. It represents a key downstream commercialization channel and use-case validator for Invibio's biomaterial innovation in joint reconstruction.

Broad incumbents

  • Mitsubishi Chemical Group (medical polymers): Mitsubishi Chemical supplies engineering plastics including high-performance polymers used in medical device applications. While broader in portfolio, its medical polymer offerings overlap with Invibio's PEEK solutions for implantable and surgical device manufacturers.
  • Victrex plc: Invibio's parent company and the original inventor of PEEK polymer with integrated monomer-to-polymer manufacturing. Victrex supplies the same PEEK polymer feedstock that Invibio qualifies for medical use, making it the closest comparator on underlying chemistry and supply chain scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

Invibio social profiles

Digital presence

Invibio compliance and trust

Trust signal

Compliance5 records

Invibio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Invibio leadership team

Management profile

Number of profiles

Invibio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Invibio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Invibio

What does Invibio do?

Invibio manufactures and supplies implant-grade PEEK polymers and biomaterial solutions to medical device companies. Its core product family, PEEK-OPTIMA, includes standard implantable grades, hydroxyapatite-enhanced (HA Enhanced) grades for bone ongrowth, AM filament for 3D printing of patient-specific implants, PEEK-CLASSIX for non-implantable medical device components, and VICTREX PC pharmaceutical-contact grades. The portfolio supports spinal cages, trauma fixation, knee arthroplasty, active implants, and drug delivery applications, paired with regulatory and technical support services.

Is Invibio a public or private company?

Invibio is a private company. It is classified as corporate owned and is currently operating.

When was Invibio founded?

Invibio was founded in 1999. It employs 101 to 250 people.

Where is Invibio based?

Invibio is headquartered in Lancaster, United Kingdom, in the Europe region.

How does Invibio make money?

Two revenue lines are on record. PEEK Polymer Materials Sales are the primary driver. The others are technical and Regulatory Support Services.

Who are Invibio's main competitors?

Direct peers on record are Syensqo (formerly Solvay Specialty), Solvay (medical-grade PEEK/chemicals), Evonik Industries (VESTAKEEP) and DSM Biomedical (a dsm-firmenich company). Emerging players are EOS GmbH (additive manufacturing for medical), Carbofix Orthopedics, 3D Systems (medical 3D printing) and Maxx Orthopedics. Broad incumbents are Mitsubishi Chemical Group (medical polymers) and Victrex plc.

Does Invibio have an API?

No public API is recorded for Invibio.

What industry is Invibio in?

Invibio's product category is Medical Biomaterials (Implantable PEEK Polymers). Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation), with a secondary code of HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comOutlook on the Active Implantable Medical Devices Market: Major Segments, Strategic Developments, and Leading CompaniesThe active implantable medical devices market is projected to grow to $42.81 billion by 2030 with an 8.8% CAGR, driven by remote patient monitoring adoption, AI-powered diagnostics, and an aging population. Key industry developments include TekniPlex Healthcare's acquisition of Seisa Medical in December 2023 to strengthen its capabilities in minimally invasive devices, and UK-based Invibio's March 2023 launch of a PEEK-OPTIMA AM filament for 3D-printed medical implants. The Business Research Company's market outlook report identifies leading players and trends shaping the sector's future.PR NewswireInvibio und Carbofix gehen Partnerschaft mit britischem Olympia-Sprinter James Ellington für neue "Passion for Progress"-Initiative einBritish Olympic sprinter James Ellington has partnered with medical device companies Invibio Biomaterial Solutions and CarboFix Orthopedics for a new initiative following his recovery from a severe motorcycle accident. The collaboration highlights the use of CarboFix's carbon fiber-reinforced PEEK-OPTIMA™ implants, supplied by Invibio, which Ellington selected to facilitate faster bone healing compared to traditional titanium nails. This partnership aims to inspire patients through Ellington's rehabilitation journey while promoting innovative biomaterials for trauma treatment.PR NewswireInvibio et Carbofix créent un partenariat avec le sprinteur olympique britannique James Ellington sur la nouvelle initiative « Passion pour le progrès »British Olympic sprinter James Ellington has partnered with UK-based Invibio Biomaterial Solutions and CarboFix Orthopedics for an initiative called 'Passion for Progress', aimed at inspiring patients recovering from traumatic injuries. Ellington, who suffered severe fractures to both legs and his pelvis in a catastrophic motorcycle collision in Tenerife earlier this year, chose CarboFix's carbon fibre composite screw over a traditional titanium option for his tibia fracture, citing its lighter weight and potential for faster healing. The companies highlight that their PEEK-OPTIMA Ultra-Reinforced composite implants allow greater micromobility and more natural bone-like behaviour compared to rigid metal implants.